Banco Santander’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.17M | Sell |
87,071
-47,066
| -35% | -$2.02M | 0.03% | 232 |
|
|
2026
Q1 | $4.93M | Buy |
134,137
+43,573
| +48% | +$2.06M | 0.04% | 205 |
|
|
2025
Q4 | $4.61M | Buy |
90,564
+5,997
| +7% | +$307K | 0.03% | 200 |
|
|
2025
Q3 | $4.69M | Sell |
84,567
-63,587
| -43% | -$3.72M | 0.04% | 205 |
|
|
2025
Q2 | $10.2M | Buy |
148,154
+19,763
| +15% | +$1.34M | 0.1% | 137 |
|
|
2025
Q1 | $8.92M | Buy |
128,391
+55,358
| +76% | +$4.57M | 0.1% | 138 |
|
|
2024
Q4 | $6.28M | Buy |
73,033
+4,162
| +6% | +$450K | 0.08% | 155 |
|
|
2024
Q3 | $8.2M | Sell |
68,871
-1,382
| -2% | -$184K | 0.1% | 146 |
|
|
2024
Q2 | $10M | Sell |
70,253
-9,334
| -12% | -$1.24M | 0.12% | 124 |
|
|
2024
Q1 | $10.2M | Sell |
79,587
-5,960
| -7% | -$709K | 0.12% | 121 |
|
|
2023
Q4 | $8.85M | Sell |
85,547
-11,148
| -12% | -$1.1M | 0.1% | 123 |
|
|
2023
Q3 | $8.79M | Sell |
96,695
-9,725
| -9% | -$857K | 0.12% | 114 |
|
|
2023
Q2 | $8.61M | Sell |
106,420
-5,444
| -5% | -$445K | 0.11% | 115 |
|
|
2023
Q1 | $8.9M | Buy |
111,864
+5,766
| +5% | +$409K | 0.13% | 89 |
|
|
2022
Q4 | $7.18M | Sell |
106,098
-11,982
| -10% | -$702K | 0.11% | 106 |
|
|
2022
Q3 | $5.88M | Buy |
118,080
+11,928
| +11% | +$639K | 0.08% | 123 |
|
|
2022
Q2 | $5.92M | Buy |
106,152
+4,876
| +5% | +$271K | 0.08% | 126 |
|
|
2022
Q1 | $5.62M | Buy |
101,276
+16,916
| +20% | +$868K | 0.06% | 166 |
|
|
2021
Q4 | $4.72M | Buy |
84,360
+7,000
| +9% | +$379K | 0.03% | 171 |
|
|
2021
Q3 | $3.71M | Hold |
77,360
| – | – | 0.02% | 192 |
|
|
2021
Q2 | $3.24M | Buy |
77,360
+6,780
| +10% | +$263K | 0.02% | 199 |
|
|
2021
Q1 | $2.38M | Buy |
70,580
+13,980
| +25% | +$498K | 0.02% | 206 |
|
|
2020
Q4 | $1.98M | Buy |
56,600
+12,760
| +29% | +$441K | 0.01% | 212 |
|
|
2020
Q3 | $1.52M | Buy |
43,840
+4,980
| +13% | +$166K | 0.02% | 207 |
|
|
2020
Q2 | $1.27M | Sell |
38,860
-38,160
| -50% | -$1.22M | 0.02% | 194 |
|
|
2020
Q1 | $2.32M | Sell |
77,020
-19,680
| -20% | -$586K | 0.03% | 192 |
|
|
2019
Q4 | $2.8M | Buy |
96,700
+9,880
| +11% | +$274K | 0.03% | 182 |
|
|
2019
Q3 | $2.25M | Sell |
86,820
-7,540
| -8% | -$191K | 0.02% | 189 |
|
|
2019
Q2 | $2.4M | Buy |
94,360
+12,080
| +15% | +$299K | 0.02% | 197 |
|
|
2019
Q1 | $2.13M | Buy |
82,280
+14,040
| +21% | +$345K | 0.02% | 185 |
|
|
2018
Q4 | $1.57M | Buy |
68,240
+4,040
| +6% | +$89.8K | 0.02% | 212 |
|
|
2018
Q3 | $1.51M | Buy |
+64,200
| New | +$1.57M | 0.02% | 215 |
|
|
2017
Q3 | – | Sell |
-86,066
| Closed | -$1.84M | – | 195 |
|
|
2017
Q2 | $1.84M | Sell |
86,066
-11,436
| -12% | -$231K | 0.04% | 101 |
|
|
2017
Q1 | $1.68M | Sell |
97,502
-3,646
| -4% | -$63.5K | 0.04% | 78 |
|
|
2016
Q4 | $1.82M | Buy |
+101,148
| New | +$1.83M | 0.05% | 79 |
|
Other funds holding NVO
F
Banco Santander's NVO Position: Q2 2026 in Review
Banco Santander reduced its Novo Nordisk (NVO) stake by 35% in Q2 2026, selling an estimated $2.02M and leaving 87,071 shares worth $4.17M. The position accounts for 0.03% of the portfolio, ranked #232.
Banco Santander first reported a position in NVO in Q4 2016 and has held it in 35 quarters since. The position peaked at $10.2M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Banco Santander held 87,071 shares of Novo Nordisk worth $4.17M as of Q2 2026.
- Banco Santander sold 47,066 Novo Nordisk shares in Q2 2026, an estimated $2.02M.
- Novo Nordisk made up 0.03% of Banco Santander's portfolio in Q2 2026, its #232 holding.
- Banco Santander first reported a position in Novo Nordisk in Q4 2016 and has held it in 35 quarters since.
- Banco Santander's Novo Nordisk position peaked at $10.2M in Q2 2025.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.